MYCN and neuroblastoma: Since many enzyme-encoding genes are actively transcribed in cells for the maintenance of basic metabolic functions, it is reasonable to speculate that the MYCN-driven global transcriptional amplification could have a profound impact on metabolic reprogramming in neuroblastoma cells.